201 related articles for article (PubMed ID: 17056557)
1. Trypanosoma cruzi-mediated IFN-gamma-inducible nitric oxide output in macrophages is regulated by iNOS mRNA stability.
Bergeron M; Olivier M
J Immunol; 2006 Nov; 177(9):6271-80. PubMed ID: 17056557
[TBL] [Abstract][Full Text] [Related]
2. Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation.
Blanchette J; Jaramillo M; Olivier M
Immunology; 2003 Apr; 108(4):513-22. PubMed ID: 12667213
[TBL] [Abstract][Full Text] [Related]
3. Hemozoin increases IFN-gamma-inducible macrophage nitric oxide generation through extracellular signal-regulated kinase- and NF-kappa B-dependent pathways.
Jaramillo M; Gowda DC; Radzioch D; Olivier M
J Immunol; 2003 Oct; 171(8):4243-53. PubMed ID: 14530348
[TBL] [Abstract][Full Text] [Related]
4. Monosodium urate crystals synergize with IFN-gamma to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1/2 and NF-kappa B.
Jaramillo M; Naccache PH; Olivier M
J Immunol; 2004 May; 172(9):5734-42. PubMed ID: 15100320
[TBL] [Abstract][Full Text] [Related]
5. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB.
Whan Han J; Gon Lee B; Kee Kim Y; Woo Yoon J; Kyoung Jin H; Hong S; Young Lee H; Ro Lee K; Woo Lee H
Br J Pharmacol; 2001 Jun; 133(4):503-12. PubMed ID: 11399667
[TBL] [Abstract][Full Text] [Related]
6. Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-kappaB and JAK/STAT pathways.
Kar S; Ukil A; Das PK
Eur J Immunol; 2009 Mar; 39(3):741-51. PubMed ID: 19197936
[TBL] [Abstract][Full Text] [Related]
7. Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microglia.
Huang C; Lu X; Tong L; Wang J; Zhang W; Jiang B; Yang R
J Neuroinflammation; 2015 Oct; 12():189. PubMed ID: 26467650
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
10. Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells.
Kim YM; Paik SG
Biochem Biophys Res Commun; 2005 Jan; 326(2):410-6. PubMed ID: 15582593
[TBL] [Abstract][Full Text] [Related]
11. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
12. Leishmania donovani amastigotes impair gamma interferon-induced STAT1alpha nuclear translocation by blocking the interaction between STAT1alpha and importin-alpha5.
Matte C; Descoteaux A
Infect Immun; 2010 Sep; 78(9):3736-43. PubMed ID: 20566692
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of connective tissue growth factor by LPS/IFN-γ-induced nitric oxide is reversed by aristolochic acid treatment in glomerular mesangial cells via STAT-1α and NF-κB signaling.
Tsai KD; Chen W; Wang SH; Hsiao YW; Chi JY; Wu HY; Lee YJ; Wong HY; Tseng MJ; Lin TH
Chem Biol Interact; 2014 Mar; 210():86-95. PubMed ID: 24412304
[TBL] [Abstract][Full Text] [Related]
14. JAK inhibitors AG-490 and WHI-P154 decrease IFN-gamma-induced iNOS expression and NO production in macrophages.
Sareila O; Korhonen R; Kärpänniemi O; Nieminen R; Kankaanranta H; Moilanen E
Mediators Inflamm; 2006; 2006(2):16161. PubMed ID: 16883061
[TBL] [Abstract][Full Text] [Related]
15. The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages.
De Stefano D; Maiuri MC; Iovine B; Ialenti A; Bevilacqua MA; Carnuccio R
J Mol Med (Berl); 2006 Jan; 84(1):65-74. PubMed ID: 16284791
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages.
Shin HM; Byung Hak Kim ; Eun Yong Chung ; Jung SH; Yeong Shik Kim ; Kyung Rak Min ; Kim Y
Eur J Pharmacol; 2005 Oct; 521(1-3):1-8. PubMed ID: 16183054
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant enzymes suppress nitric oxide production through the inhibition of NF-kappa B activation: role of H(2)O(2) and nitric oxide in inducible nitric oxide synthase expression in macrophages.
Han YJ; Kwon YG; Chung HT; Lee SK; Simmons RL; Billiar TR; Kim YM
Nitric Oxide; 2001; 5(5):504-13. PubMed ID: 11587565
[TBL] [Abstract][Full Text] [Related]
18. HO-1 and JAK-2/STAT-1 signals are involved in preferential inhibition of iNOS over COX-2 gene expression by newly synthesized tetrahydroisoquinoline alkaloid, CKD712, in cells activated with lipopolysacchride.
Tsoyi K; Kim HJ; Shin JS; Kim DH; Cho HJ; Lee SS; Ahn SK; Yun-Choi HS; Lee JH; Seo HG; Chang KC
Cell Signal; 2008 Oct; 20(10):1839-47. PubMed ID: 18634870
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
[TBL] [Abstract][Full Text] [Related]
20. Reduced nitric oxide production and iNOS mRNA expression in IFN-gamma-stimulated chicken macrophages transfected with iNOS siRNAs.
Cheeseman JH; Lillehoj HS; Lamont SJ
Vet Immunol Immunopathol; 2008 Oct; 125(3-4):375-80. PubMed ID: 18586326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
